We are live on ! Find out more
PFO

Pathstone Family Office Portfolio holdings

AUM $13.1B
1-Year Est. Return 21.02%
This Fund
S&P 500
This Quarter Est. Return
+3.46%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.47%
10 Year Est. Return
+236.85%
AUM
$237M
AUM Growth
+$55.9M
Cap. Flow
+$50.9M
Cap. Flow %
21.44%
Top 10 Hldgs %
68.51%
Holding
729
New
76
Increased
83
Reduced
120
Closed
343

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.93M
2
EFOR
Everforth Inc
EFOR
+$1.81M
3
F icon
Ford
F
+$1.74M
4
VNQ icon
Vanguard Real Estate ETF
VNQ
+$1.05M
5
XYL icon
Xylem
XYL
+$747K

Sector Composition

Rank Sector Weight
1 Financials 23.74%
2 Consumer Discretionary 10.93%
3 Technology 10.32%
4 Healthcare 4.2%
5 Industrials 3.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KDNY
676
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-6
Closed
IVH
677
DELISTED
Delaware Ivy High Income Opportunities Fund
IVH
-269
Closed -$4K
CLR
678
DELISTED
CONTINENTAL RESOURCES INC.
CLR
-23
Closed -$1K
BRG
679
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
-37
Closed
CTXS
680
DELISTED
Citrix Systems Inc
CTXS
-45
Closed -$3K
XLNX
681
DELISTED
Xilinx Inc
XLNX
-33
Closed -$2K
GWB
682
DELISTED
Great Western Bancorp, Inc.
GWB
-13
Closed -$1K
SC
683
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
-65
Closed -$1K
NXQ
684
DELISTED
NUVEEN ELECT TAX-FREE INC 2
NXQ
-281
Closed -$4K
VTA
685
DELISTED
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
-2,540
Closed -$31K
MXIM
686
DELISTED
Maxim Integrated Products
MXIM
-8
Closed
BPY
687
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
-400
Closed -$9K
ALXN
688
DELISTED
Alexion Pharmaceuticals
ALXN
-12
Closed -$1K
PTVCB
689
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
-13
Closed
HTZ
690
DELISTED
Hertz Global Holdings, Inc.
HTZ
-13
Closed
ETFC
691
DELISTED
E*Trade Financial Corporation
ETFC
-21
Closed -$1K
LOGM
692
DELISTED
LogMein, Inc.
LOGM
-7
Closed -$1K
LM
693
DELISTED
Legg Mason, Inc.
LM
-37
Closed -$1K
STML
694
DELISTED
Stemline Therapeutics, Inc.
STML
-91
Closed -$1K
PKD
695
DELISTED
Parker Drilling Company
PKD
-10
Closed
VSI
696
DELISTED
Vitamin Shoppe Inc.
VSI
-14
Closed
ISCA
697
DELISTED
International Speedway Corp
ISCA
-9
Closed
VSM
698
DELISTED
Versum Materials, Inc.
VSM
-1
Closed
LEXEA
699
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
-4
Closed
HZNP
700
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-28
Closed

Similar funds

Pathstone Family Office's Q2 2017 Portfolio in Review

As of Q2 2017, Pathstone Family Office held 729 positions worth $237M, up 31% from $181M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Pathstone Family Office deployed $50.9M of net new capital in Q2 2017, opening 76 new positions and adding to 83 existing holdings. Its largest new stake was iShares Core High Dividend ETF: 233,470 shares worth $3.88M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 30% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Gilead Sciences, an estimated $3.93M trimmed.

  • Pathstone Family Office's largest Q2 2017 buy was iShares Core High Dividend ETF: 233,470 shares worth $3.88M.
  • Pathstone Family Office added most to iShares Core S&P 500 ETF in Q2 2017, an estimated $18.4M increase.
  • Pathstone Family Office's biggest Q2 2017 reduction was Gilead Sciences, cutting an estimated $3.93M.
  • Pathstone Family Office fully exited Ford in Q2 2017, selling an estimated $1.74M.
  • Pathstone Family Office's ten largest holdings make up 69% of its $237M portfolio in Q2 2017.
  • Pathstone Family Office opened 76 new positions and closed 343 in Q2 2017.
  • Pathstone Family Office's portfolio value rose 31% quarter-over-quarter to $237M.

Based on Pathstone Family Office's 13F filing for Q2 2017, filed 11 Aug 2017.